RESEARCHER PROFILE

Бабышкина Наталия Николаевна

← Back to Siberian State Medical University

Б

Siberian State Medical University

Breast Cancer Treatment StudiesEstrogen and related hormone effectsBreast Lesions and CarcinomasBRCA gene mutations in cancerColorectal Cancer Treatments and Studies

Бабышкина Наталия Николаевна works in Breast Cancer Treatment Studies, Estrogen and related hormone effects, Breast Lesions and Carcinomas, BRCA gene mutations in cancer, Colorectal Cancer Treatments and Studies. Recorded institutional associations include Russian Academy of Sciences, Siberian State Medical University, Tomsk National Research Medical Center.

104Publications
208Citations
10H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Crosstalk Between the FGFR2 and TP53 Genes in Breast Cancer: Data from an Association Study and Epistatic Interaction Analysis

    2011 · 24 citations
  2. Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

    2017 · 22 citations
  3. Role of TGF-β signaling in the mechanisms of tamoxifen resistance

    2021 · 17 citations
  4. Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population

    2014 · 15 citations
  5. [Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women].

    2008 · 15 citations
  6. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer

    2019 · 15 citations
  7. The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients

    2013 · 13 citations
  8. The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen

    2016 · 11 citations
  9. New germline mutations in non-BRCA genes among breast cancer women of Mongoloid origin

    2020 · 11 citations
  10. Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients

    2021 · 10 citations
  11. Association of functional −509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population

    2011 · 7 citations
  12. Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer

    2018 · 6 citations
  13. Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin

    2022 · 4 citations
  14. Mesenchymal Subtype of Triple-Negative Breast Cancer: A Review of Specific Features

    2023 · 4 citations
  15. Рецептор фактора роста сосудистого эндотелия типа II (VEGFR2) вносит вклад в формирование резистентности эстрогенположительного рака молочной железы к тамоксифену

    2020 · 3 citations
  16. PI3K/AKT/MTOR: CONTRIBUTION TO THE TUMOR PHENOTYPE SENSITIVE TO TAMOXIFEN

    2021 · 3 citations
  17. Exome Sequencing: the Search for Mutations Associated with Hereditary Breast and Ovarian Cancers in the Tuvan Ethnic Group (A Pilot Study)

    2024 · 3 citations
  18. A Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients

    2024 · 3 citations
  19. Impact of neoadjuvant chemotargeted therapy in patients with colorectal cancer and synchronous liver metastases in perioperative period

    2024 · 3 citations
  20. The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

    2020 · 2 citations
  21. New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman

    2022 · 2 citations
  22. Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis

    2022 · 2 citations
  23. ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER

    2016 · 2 citations
  24. Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report

    2024 · 2 citations
  25. Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group

    2026 · 2 citations

← Return to the university profile